North America Allergy Diagnostics And Therapeutics Market Size & Outlook
North America allergy diagnostics and therapeutics market, 2018-2030 (US$M)
Related Markets
North America allergy diagnostics and therapeutics market highlights
- The North America allergy diagnostics and therapeutics market generated a revenue of USD 11,421.0 million in 2023.
- The market is expected to grow at a CAGR of 6.9% from 2024 to 2030.
- In terms of segment, inhaled was the largest revenue generating allergen type in 2023.
- Food is the most lucrative allergen type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 11,421.0 million |
| Market revenue in 2030 | USD 18,241.7 million |
| Growth rate | 6.9% (CAGR from 2023 to 2030) |
| Largest segment | Inhaled |
| Fastest growing segment | Food |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Inhaled, Drug, Other Allergens, Food |
| Key market players worldwide | Rohm Co Ltd, Thermo Fisher Scientific Inc, PerkinElmer, BioMerieux SA, Siemens Healthineers AG ADR, Omega Healthcare Investors Inc, Danaher Corp, Alcon Inc, AbbVie Inc, Sanofi SA, Allergy Therapeutics PLC, Pfizer Inc, Teva Pharmaceutical Industries Ltd, GSK PLC, Sun Pharmaceutical Industries, Roche Holding AG, Merck & Co Inc, Astellas Pharma Inc, Epigenomics AG |
Other key industry trends
- In terms of revenue, North America region accounted for 36.4% of the global allergy diagnostics and therapeutics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 9,489.1 million by 2030.
Inhaled was the largest segment with a revenue share of 45.57% in 2023. Horizon Databook has segmented the North America allergy diagnostics and therapeutics market based on inhaled, drug, other allergens, food covering the revenue growth of each sub-segment from 2018 to 2030.
North America held the dominant share of allergy diagnostics and therapeutics market in 2022 owing to factors such as the rising incidence of allergy and favorable government initiatives in the region. North America is a developed region with high healthcare expenditure.
The presence of regulatory entities in North American countries is expected to boost the advancement of drugs in the near future. This is mainly because these entities play a pivotal role in creating awareness among people about the potential of early diagnosis and therapeutics of allergies.
The region held a major market share due to an increase in understanding of the high potential associated with allergy drugs. This has driven U.S.-based firms to make considerable investments in the development of these drugs.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Allergy Diagnostics And Therapeutics Market Scope
Allergy Diagnostics And Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America allergy diagnostics and therapeutics market size, by country, 2018-2030 (US$M)
North America Allergy Diagnostics And Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
